218 related articles for article (PubMed ID: 14738659)
1. Screening for liver cancer: results of a randomised controlled trial in Qidong, China.
Chen JG; Parkin DM; Chen QG; Lu JH; Shen QJ; Zhang BC; Zhu YR
J Med Screen; 2003; 10(4):204-9. PubMed ID: 14738659
[TBL] [Abstract][Full Text] [Related]
2. [Study on screening for primary liver cancer in high risk population of an endemic area].
Chen JG
Zhonghua Yu Fang Yi Xue Za Zhi; 1991 Nov; 25(6):325-8. PubMed ID: 1726199
[TBL] [Abstract][Full Text] [Related]
3. [A thirty-one year prospective follow-up program on the HBsAg carrier state and primary liver cancer in Qidong, China].
Chen JG; Lu JH; Zhu YR; Zhu J; Zhang YH
Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Jul; 31(7):721-6. PubMed ID: 21162830
[TBL] [Abstract][Full Text] [Related]
4. [Population-based survival analysis of primary liver cancer in a high-incidence area-Qidong, China during 1972-1991].
Chen J; Sankaranrayanan R; Li W
Zhonghua Yu Fang Yi Xue Za Zhi; 1997 May; 31(3):149-52. PubMed ID: 9812592
[TBL] [Abstract][Full Text] [Related]
5. [Significance of prospective follow-up cohort study in diagnosis and treatment of primary hepatic cancer among HBsAg carriers].
Lu P; Wang J; Wu Y
Zhonghua Yi Xue Za Zhi; 2001 Jul; 81(14):856-9. PubMed ID: 11702680
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ
J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774
[TBL] [Abstract][Full Text] [Related]
7. [Changes of clinical aspect of primary liver cancer in China during the past 30 years--control study for 3,250 cases with primary liver cancer].
Yang BH; Xia JL; Huang LW; Tang ZY; Chen MS; Li JQ; Liang AM; Mo QG; Lu HS; Dai CL; Yan LN; Yu ZJ; Rao RS; Li LQ; Su ZX; Fang ZW
Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(12):1053-7. PubMed ID: 12899777
[TBL] [Abstract][Full Text] [Related]
8. [A prospective study of early detection for primary liver cancer].
Yang B; Zhang B; Xu Y
Zhonghua Zhong Liu Za Zhi; 1996 Nov; 18(6):442-4. PubMed ID: 9387298
[TBL] [Abstract][Full Text] [Related]
9. Cancer high-risk subjects identified by serum pepsinogen tests: outcomes after 10-year follow-up in asymptomatic middle-aged males.
Yanaoka K; Oka M; Mukoubayashi C; Yoshimura N; Enomoto S; Iguchi M; Magari H; Utsunomiya H; Tamai H; Arii K; Ohata H; Fujishiro M; Takeshita T; Mohara O; Ichinose M
Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):838-45. PubMed ID: 18398025
[TBL] [Abstract][Full Text] [Related]
10. [Screening and early diagnosis of primary liver cancer].
Yang B; Zhang B; Tang Z
Zhonghua Gan Zang Bing Za Zhi; 1999 Sep; 7(3):130-1. PubMed ID: 10572674
[TBL] [Abstract][Full Text] [Related]
11. [Hepatitis B virus infection and aflatoxin exposure in the development of primary liver cancer].
Lu P; Kuang S; Wang J
Zhonghua Yi Xue Za Zhi; 1998 May; 78(5):340-2. PubMed ID: 10923435
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up study of a population-based 1996-1998 mass screening programme for lung cancer using mobile low-dose spiral computed tomography.
Sone S; Nakayama T; Honda T; Tsushima K; Li F; Haniuda M; Takahashi Y; Suzuki T; Yamanda T; Kondo R; Hanaoka T; Takayama F; Kubo K; Fushimi H
Lung Cancer; 2007 Dec; 58(3):329-41. PubMed ID: 17675180
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of secular trend of liver cancer incidence in Qidong, Jiangsu province, 1973-2002].
Chen JG; Zhu J; Zhang YH; Zhu YR; Lu JH
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3052-6. PubMed ID: 16324406
[TBL] [Abstract][Full Text] [Related]
14. Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial.
Weissfeld JL; Schoen RE; Pinsky PF; Bresalier RS; Church T; Yurgalevitch S; Austin JH; Prorok PC; Gohagan JK;
J Natl Cancer Inst; 2005 Jul; 97(13):989-97. PubMed ID: 15998952
[TBL] [Abstract][Full Text] [Related]
15. [Early diagnosis and early treatment for liver cancer in Qidong: survival of patients and effectiveness of screening].
Chen JG; Zhang YH; Zhu J; Lu JH; Wang JB; Sun Y; Xue XF; Lu LL; Chen YS; Wu Y; Jiang XP; Ding LL; Zhang QN; Zhu YR
Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):946-951. PubMed ID: 29262514
[No Abstract] [Full Text] [Related]
16. [The prevention of primary liver cancer by selenium in high risk populations].
Li W; Zhu Y; Yan X; Zhang Q; Li X; Ni Z; Shen Z; Yao H; Zhu J
Zhonghua Yu Fang Yi Xue Za Zhi; 2000 Nov; 34(6):336-8. PubMed ID: 11860943
[TBL] [Abstract][Full Text] [Related]
17. Acceleration to death from liver cancer in people with hepatitis B viral mutations detected in plasma by mass spectrometry.
Chen JG; Kuang SY; Egner PA; Lu JH; Zhu YR; Wang JB; Zhang BC; Chen TY; Muñoz A; Kensler TW; Groopman JD
Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1213-8. PubMed ID: 17548687
[TBL] [Abstract][Full Text] [Related]
18. Overall survival in the intervention arm of a randomized controlled screening trial for prostate cancer compared with a clinically diagnosed cohort.
Vis AN; Roemeling S; Reedijk AM; Otto SJ; Schröder FH
Eur Urol; 2008 Jan; 53(1):91-8. PubMed ID: 17583416
[TBL] [Abstract][Full Text] [Related]
19. Colorectal cancer screening using fecal occult blood test and subsequent risk of colorectal cancer: a prospective cohort study in Japan.
Lee KJ; Inoue M; Otani T; Iwasaki M; Sasazuki S; Tsugane S;
Cancer Detect Prev; 2007; 31(1):3-11. PubMed ID: 17289293
[TBL] [Abstract][Full Text] [Related]
20. Age-specific interval breast cancers in New South Wales and meta-analysis of studies of women aged 40-49 years.
Taylor R; Page A; Bampton D; Estoesta J; Rickard M
J Med Screen; 2004; 11(4):199-206. PubMed ID: 15563775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
